Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-30 | New | $10,288,140 | $10,288,140 | Equity Only | 06b | SEC link |
| 2021-09-07 | New | $3,519,169 | Unknown | Equity Only | SEC link | |
| 2019-11-25 | New | $1,450,001 | $1,450,001 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Michael Kope | Director, Executive |
| Matthew O'connor | Director, Executive |
| Frank Schueler | Director |